raw_text
stringlengths 1
32.6k
| topic
stringlengths 0
7.81k
| speciallity
stringlengths 0
111
| raw_text_type
stringclasses 3
values | topic_type
stringclasses 6
values | source
stringclasses 13
values | country
stringclasses 2
values | document_id
stringlengths 0
47
|
|---|---|---|---|---|---|---|---|
Condrosarcoma grado 2
|
Proceso neoplásico
|
question
|
answer
|
13
|
es
|
99086
|
|
Durvalumab
|
Aminoácido péptido o proteína
|
question
|
answer
|
13
|
es
|
99087
|
|
Durvalumab
|
Factor inmunológico
|
question
|
answer
|
13
|
es
|
99087
|
|
Durvalumab
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99087
|
|
Avelumab
|
Aminoácido péptido o proteína
|
question
|
answer
|
13
|
es
|
99088
|
|
Avelumab
|
Factor inmunológico
|
question
|
answer
|
13
|
es
|
99088
|
|
Avelumab
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99088
|
|
Atezolizumab
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99089
|
|
Atezolizumab
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99089
|
|
Tipiracilo
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99090
|
|
Tipiracilo
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99090
|
|
Tolak
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99091
|
|
Tolak
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99091
|
|
Imlygic
|
Virus
|
question
|
answer
|
13
|
es
|
99092
|
|
Seebri
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99093
|
|
Seebri
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99093
|
|
Mesilato de osimertinib
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99094
|
|
Mesilato de osimertinib
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99094
|
|
Osimertinib
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99095
|
|
Osimertinib
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99095
|
|
Tagrisso
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99096
|
|
Tagrisso
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99096
|
|
Darzalex
|
Aminoácido péptido o proteína
|
question
|
answer
|
13
|
es
|
99097
|
|
Darzalex
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99097
|
|
Cotellic
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99098
|
|
Cotellic
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99098
|
|
Fumarato de cobimetinib
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99099
|
|
Fumarato de cobimetinib
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99099
|
|
Passiflora incarnata
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99100
|
|
Passiflora incarnata
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99100
|
|
Alecensa
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99101
|
|
Alecensa
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99101
|
|
Empliciti
|
Aminoácido péptido o proteína
|
question
|
answer
|
13
|
es
|
99102
|
|
Empliciti
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99102
|
|
Bendeka
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99103
|
|
Bendeka
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99103
|
|
Citrato de ixazomib
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99104
|
|
Citrato de ixazomib
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99104
|
|
Ninlaro
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99105
|
|
Ninlaro
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99105
|
|
Portrazza
|
Aminoácido péptido o proteína
|
question
|
answer
|
13
|
es
|
99106
|
|
Portrazza
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99106
|
|
Expresivo
|
Comportamiento
|
question
|
answer
|
13
|
es
|
99107
|
|
Infiltración tumoral
|
Proceso neoplásico
|
question
|
answer
|
13
|
es
|
99108
|
|
Anestesia combinada
|
Procedimiento terapéutico o preventivo
|
question
|
answer
|
13
|
es
|
99109
|
|
Mefítico
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99110
|
|
Autoerótico
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99111
|
|
Trauma facial
|
Lesión o envenenamiento
|
question
|
answer
|
13
|
es
|
99112
|
|
Impotencia funcional
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99113
|
|
Comportamiento premórbido
|
Comportamiento
|
question
|
answer
|
13
|
es
|
99114
|
|
Alteración de concentración
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99115
|
|
Problema de concentración
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99116
|
|
Arco reflejo
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99117
|
|
Obstrucción mecánica
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99118
|
|
Vacuna antimeningocócica acwy
|
Factor inmunológico
|
question
|
answer
|
13
|
es
|
99119
|
|
Vacuna antimeningocócica acwy
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99119
|
|
Electrodo de referencia
|
Dispositivo médico
|
question
|
answer
|
13
|
es
|
99120
|
|
Concentración alveolar mínima
|
Concepto cuantitativo
|
question
|
answer
|
13
|
es
|
99121
|
|
Masa en el miocardio
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99122
|
|
Masa miocárdica
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99123
|
|
Holosistólico
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99124
|
|
Mesosistólico
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99125
|
|
Mesodiastólico
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99126
|
|
Tortuoso
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99127
|
|
Neovascular
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99128
|
|
Pseudohipopión
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99129
|
|
Anogenital
|
Ubicación del cuerpo o región
|
question
|
answer
|
13
|
es
|
99130
|
|
Paquimetría
|
Procedimiento diagnóstico
|
question
|
answer
|
13
|
es
|
99131
|
|
Paquimétrico
|
Procedimiento diagnóstico
|
question
|
answer
|
13
|
es
|
99132
|
|
Pérdida brusca de la agudeza visual
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99133
|
|
Cierre prematuro de bregma
|
Hallazgo
|
question
|
answer
|
13
|
es
|
99134
|
|
Carcinoide atípico pulmonar
|
Proceso neoplásico
|
question
|
answer
|
13
|
es
|
99135
|
|
Tumor carcinoide atípico pulmonar
|
Proceso neoplásico
|
question
|
answer
|
13
|
es
|
99136
|
|
Paracentral
|
Concepto espacial
|
question
|
answer
|
13
|
es
|
99137
|
|
Pericentral
|
Concepto espacial
|
question
|
answer
|
13
|
es
|
99138
|
|
Esterilidad
|
Función patológica
|
question
|
answer
|
13
|
es
|
99139
|
|
Miniexamen cognoscitivo
|
Procedimiento diagnóstico
|
question
|
answer
|
13
|
es
|
99140
|
|
Eje hipotálamo-hipófiso-gonadal
|
Sistema corporal
|
question
|
answer
|
13
|
es
|
99141
|
|
Eje hipotálamo-hipófiso-suprarrenal
|
Sistema corporal
|
question
|
answer
|
13
|
es
|
99142
|
|
Glándula de brunner
|
Parte del cuerpo órgano o componente del órgano
|
question
|
answer
|
13
|
es
|
99143
|
|
Gingivitis generalizada
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99144
|
|
Unidad de recuperación
|
Objeto fabricado
|
question
|
answer
|
13
|
es
|
99145
|
|
Bacteria multirresistente
|
Bacteria
|
question
|
answer
|
13
|
es
|
99146
|
|
Terapia de rescate con lípidos
|
Procedimiento terapéutico o preventivo
|
question
|
answer
|
13
|
es
|
99147
|
|
Ckd-mbd
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99148
|
|
Enfermedad crónica del riñón-trastorno mineral y óseo
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99149
|
|
Enfermedad renal crónica-trastorno mineral y óseo
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99150
|
|
Insuficiencia renal crónica-trastorno mineral y óseo
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99151
|
|
Irc-tmo
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99152
|
|
Osteodistrofia renal
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99153
|
|
Trastorno mineral y óseo asociado a enfermedad renal crónica
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99154
|
|
Trastorno mineral y óseo por enfermedad renal crónica
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99155
|
|
Trastorno óseo-mineral asociado a enfermedad renal crónica
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99156
|
|
Cáncer de próstata con metástasis ósea
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99157
|
|
Neoplasia maligna primaria de próstata con metástasis óseas
|
Enfermedad o síndrome
|
question
|
answer
|
13
|
es
|
99158
|
|
Acalabrutinib
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99159
|
|
Acalabrutinib
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99159
|
|
Valbenazina
|
Aminoácido péptido o proteína
|
question
|
answer
|
13
|
es
|
99160
|
|
Valbenazina
|
Sustancia farmacológica
|
question
|
answer
|
13
|
es
|
99160
|
|
Braftovi
|
Orgánico químico
|
question
|
answer
|
13
|
es
|
99161
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.